B. Pramanik

发表

A Phase I trial of the farnesyltransferase inhibitor L-778,123 and radiotherapy for locally advanced lung and head and neck cancer.

S. Hahn, J. Tepper, P. Deutsch, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Native Oxyntomodulin Has Significant Glucoregulatory Effects Independent of Weight Loss in Obese Humans With and Without Type 2 Diabetes

C. Beals, D. Kelley, R. Shankar, 2018, Diabetes.

Isolation and Characterization of Novel Human Immunodeficiency Virus Integrase Inhibitors from Fungal Metabolites

F. Bushman, D. Hazuda, C. Farnet, 1999, Antiviral chemistry & chemotherapy.

Equivalent inhibition of half-site and full-site retroviral strand transfer reactions by structurally diverse compounds

D. Hazuda, D. Grandgenett, J. Hastings, 1997, Journal of virology.

Odanacatib, a selective cathepsin K inhibitor to treat osteoporosis: safety, tolerability, pharmacokinetics and pharmacodynamics--results from single oral dose studies in healthy volunteers.

L. V. Van Bortel, J. Wagner, K. Lasseter, 2013, British journal of clinical pharmacology.

Pramanicin, a novel antimicrobial agent from a fungal fermentation

R. Schwartz, G. Helms, K. Wilson, 1994 .

Differential divalent cation requirements uncouple the assembly and catalytic reactions of human immunodeficiency virus type 1 integrase

D. Hazuda, J. Hastings, A. Wolfe, 1997, Journal of virology.

A Glucan Synthase FKS1 Homolog inCryptococcus neoformans Is Single Copy and Encodes an Essential Function

J. Perfect, Weili Li, John R. Thompson, 1999, Journal of bacteriology.

A Phase I Trial of the Dual Farnesyltransferase and Geranylgeranyltransferase Inhibitor L-778,123 and Radiotherapy for Locally Advanced Pancreatic Cancer

E. Rosato, J. Tepper, P. Deutsch, 2004, Clinical Cancer Research.

Effect of Laropiprant, a PGD2 Receptor 1 Antagonist, on Estradiol and Norgestimate Pharmacokinetics After Oral Contraceptive Administration in Women

J. Wagner, M. Gutierrez, J. Schwartz, 2009, American journal of therapeutics.

Characterization of a soluble stable human cytomegalovirus protease and inhibition by M-site peptide mimics

D. Hazuda, R. Lafemina, A. Marcy, 1996, Journal of virology.

Effect of Laropiprant, a PGD2 Receptor 1 Antagonist, on Estradiol and Norgestimate Pharmacokinetics After Oral Contraceptive Administration in Women

J. Wagner, M. Gutierrez, J. Schwartz, 2009, American journal of therapeutics.